002365SZSE

Announcement of Resolutions of the 14th Meeting of the 7th Board of Directors

✨ AI Summary

The 14th meeting of the 7th Board of Directors of Qianjiang Yong'an Pharmaceutical Co., Ltd. was held on April 15, 2026. The board approved the 2025 work reports, the 2025 annual report, and the 2025 profit distribution plan. The plan proposes a cash dividend of RMB 1 per 10 shares. The company also resolved to re-appoint the accounting firm.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Stock Code: 002365 Stock Abbreviation: Yong'an Pharmaceutical Announcement No.: 2026-16

Qianjiang Yong'an Pharmaceutical Co., Ltd. Announcement of Resolutions of the 14th Meeting of the 7th Board of Directors

The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and are free from any false representations, misleading statements, or material omissions.

The notice for the 14th meeting of the 7th Board of Directors of Qianjiang Yong'an Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") was delivered to all directors in written, telephone, and email formats on April 3, 2026. The meeting was held on April 15, 2026, in the Company's conference room, combining on-site and remote communication methods. A total of 7 directors were eligible to attend, and 7 directors actually attended. Some senior management personnel of the Company attended the meeting. The convening and holding of this meeting comply with the provisions of the "Company Law" and the "Articles of Association." The meeting voted on each item by written ballot, and the following resolutions were passed:

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.